BOSTON, Jan. 08, 2026 -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed...
Reactive Biosciences
Reactive Bioscience is using the world’s leading boron-based discovery platform to discover and develop medicines in innovative and imaginative new ways.
Website
